Glial fibrillary acidic protein levels pinpoint future dementia risk a decade in advance

Researchers identify GFAP as a potent biomarker for predicting dementia risk over a decade before clinical diagnosis, underscoring its potential for early screening and intervention in asymptomatic individuals.

AstraZeneca may pull plug on UK vaccine manufacturing plans – Pharmaceutical Technology

AstraZeneca may move vaccine manufacturing facilities from the UK to the US, amid potential changes to state financial aid. Credit: Nathan Stirk via Getty Images.

August 23, 2024

J&J expands Tremfya into IBD with new FDA approval

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 12, 2024

ctDNA Analysis Not Enough to Guide Treatment Decisions in Early Pancreatic Cancer

CHICAGO — The use of circulating tumor (ct)DNA analysis following upfront surgery for early-stage pancreatic cancer to guide treatment decision making did not appear to

June 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.